Report: Moderna and Feds Fight Over Coronavirus Vaccine Clinical Trials
Gearing up for a phase 3 clinical trial of its coronavirus vaccine candidate, mRNA-1273, Moderna (NASDAQ: MRNA) is apparently butting heads with federal government officials. Tensions between the company and the officials have delayed the start of the trial. This is according to a report on Tuesday by Reuters that cited three sources familiar with the vaccine project.
The sources say that Moderna and the government, specifically the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), plus outside medical experts brought in by the NIH are at odds over numerous elements of the testing. These include the protocols of the trials, patient monitoring, and information sharing.
Image source: Getty Images.
Source Fool.com
